Translational Pharmacology of CNS and Metabolic Disorders for Testing Mew Modality Therapies

Showing results for 
Search instead for 
Did you mean: 

Translational Pharmacology of CNS and Metabolic Disorders for Testing Mew Modality Therapies

ACS Webinars Hub Placeholder Image.png
Published on ‎07-31-2023 09:55 AM by | Updated on ‎08-23-2023 01:11 PM

Animal studies may provide a close approximation to humans when addressing the key challenge of clinical translatability.  In the preclinical setting, new insights into disease models and mechanisms are crucial to efficacy studies.  In this webinar, we will share our experiences and insights of the mechanistic aspects of preclinical pharmacology in the areas of neurodegenerative diseases, NASH, and metabolic disorders (involving PCSK9, in particular).  Additional discussion will focus on how such insights are used in testing new modalities such as oligonucleotides and AAV that target the CNS or the liver. 
Key Learning Objectives:
  • Review spontaneous Alzheimer-like dementia, diet-induced NASH and other metabolic diseases in small and large animals
  • Dive into the clinical relevance of NASH models and insight into hepatic fibrosis 
  • Learn how PCSK9 expression levels and/or activity are affected under metabolic induction
  • See how these mechanistic insights can help in testing new modalities 
Who Should Attend:
  • Project Managers in Drug Discovery 
  • Program Leaders and Directors of Drug Discovery 
  • Scientists in Drug Discovery, including Medicinal Chemists, In Vivo Biologists in Neurodegenerative Diseases and NASH and other Metabolic Diseases, Pharmacologists, etc. 
  • Scientists who are interested in new modality therapies

Brought to you by:
%7B3d0ccb3e-30a7-49eb-a759-f98c89052916%7D_Speaker_100x100Deming Xu, Ph.D.
Chief Pharmacologist, Executive Director, Head of In Vivo Pharmacology,
WuXi AppTec Discovery Biology

%7Bcdccb62d-4f94-40ad-b78d-37a1fa5cc717%7D__kellymcsweeney_croppedKelly McSweeney
Contributing Editor,
C&EN Media Group

Event has ended
You can no longer attend this event.

Tue, Aug 29, 2023 11:00 AM EDT
Tue, Aug 29, 2023 12:00 PM EDT
<a href=''>Register</a>
Labels (2)
0 Kudos